Dall’11 al 14 ottobre 2022, ReiThera parteciperà al 29° Congresso ESGCT in collaborazione con la British Society for Gene & Cell Therapy nell’ International Conference Centre di Edimburgo. [...]
Despite the successful deployment of efficacious vaccines and therapeutics, the development of novel vaccines for SARS-CoV-2 remains a major goal to increase vaccine doses availability and [...]
